Wegovy

Weight loss drugs like Ozempic and Wegovy have been everywhere in 2023. And as the injectable diabetes medication millions of people swear by for weight loss becomes more popular, its other benefits (and drawbacks) are being studied more…

Over 55 million people worldwide have dementia. This mind-robbing disease has a huge impact on society and the economy, so scientists are working hard to find ways to treat or prevent it. One of the avenues being explored is the new…

Ozempic is a prescription drug that's been all over the news in the past year. Although it's a type 2 diabetes drug, Ozempic has been widely touted as a weight-loss cure.…

Longtime users of Wegovy who stop using the drug will sometimes suffer major blood sugar spikes that leave them hospitalized, experts warn. Both Wegovy and its sister drug Ozempic use the active ingredient semaglutide. The drug works by…

Game-changing weight loss jabs could potentially help in the fight against cancer, research suggests.Wegovy, Ozempic and other fat-melting injections have ushered in a new era in the war on obesity.Now experts have discovered the drugs may…

Scientists believe groundbreaking weight loss drugs could also serve as a treatment for dementia.Wegovy, Ozempic and Mounjaro are being trialed as medication for neurological conditions by scientists in the US and Europe.It is believed that…

Anti-obesity drugs could be the pharmaceutical industry’s biggest golden ticket yet - with analysts forecasting over $100 billion in profits in the coming decade. An estimated one in 60 US adults currently has a prescription for one of the…

Topline Novo Nordisk, the manufacturer of weight-loss drug Wegovy, announced Thursday it was limiting the supply of the medication’s starter doses as a response to the drug’s growing demand, but research shows patients who stop taking the…

Distributor Novo Nordisk has decided to limit low doses of obesity medication Wegovy in the U.S. as demand outpaces supply. Novo Nordisk, a global healthcare and pharmaceutical company based in Denmark, is limiting the supply of…

Eli Lilly seeks FDA approval for weight loss drug…